FMC Q1 2026 Results: Cash Conversion Remains Elusive, No Material Improvement on Collections

What happened

FMC reported Q1 2026 earnings, revealing persistent operating cash flow weakness driven by ongoing Latin America receivable delays. Despite earlier expectations of a catch-up by early 2026, collections improved only marginally and remained below normalized levels. The company continued to rely on receivables monetization tools, with securitization and factoring volumes roughly flat versus Q1 2025. Management maintained its full-year 2026 free cash flow guidance of -$65M to $65M, signaling no near-term inflection. Covenant headroom improved modestly as net debt was essentially unchanged, but the balance sheet remains constrained with leverage still near the 5.25x limit.

Implication

Without a clear operating cash flow positive quarter without elevated factoring, the stock will trade range-bound near $16-17. Investors should wait for evidence of sustained cash conversion before adding exposure, as the bear case of late collections into mid-2026 gains traction.

Thesis delta

The Q1 print confirms that cash conversion is not yet normalizing; the bear case of delayed collections into mid-2026 becomes more likely, reducing confidence in a near-term turnaround. The wait-and-see stance is reinforced, and attractive entry at $14 remains appropriate only if operating cash flow inflects by Q2 2026.